St. Jude Bird Flu Vaccine Test Successful
Posted on: Tuesday, 2 May 2006, 15:01 CDT
U.S. scientists say a commercially developed vaccine has successfully protected mice and ferrets against a highly lethal avian influenza virus.
The research, conducted at St. Jude Children's Research Hospital in Memphis, Tenn., involved a vaccine developed by Vical Inc. of San Diego, Calif.
Richard Webby, an assistant faculty member in St. Jude's infectious diseases department, said the finding, coupled with results of previous studies, suggests such a vaccine would protect humans against multiple variants of the bird and human influenza viruses, including the H5N1 virus that might mutate so it can spread readily from person to person.
Flu experts and public health officials fear such an H5N1 variant would trigger a human pandemic.
Webby was to present the study Wednesday in Denver, Colo., during a U.S. Public Health Service Professional Conference.
Source: United Press International
Related Articles
- Panel Warns on Danger of Smallpox Vaccine
- Bush Signs Smallpox Vaccine Compensation
- Altered Smallpox Vaccine May Fight Cancer
- Second Death After Smallpox Vaccine
- Alzheimer's Vaccine Had Mixed Results
- Senate Head to Get Smallpox Vaccination
- CDC Director Receives Smallpox Vaccine
- Bacterial Viruses Make Cheap Easy Vaccines
- New AIDS Vaccine Shows Some Promise
- No Serious Reactions to Smallpox Vaccine
 |
 |
User Comments (0)
RSS Feeds